Jackie Tohn joins Myriad Genetics in campaign to expand hereditary cancer test awareness

Jackie Tohn joins Myriad Genetics in campaign to expand hereditary cancer test awareness
Myriad Genetics and Jackie Tohn unite

Myriad Genetics has entered into a partnership with actress Jackie Tohn to raise public awareness on the importance of hereditary cancer testing using its MyRisk Hereditary Cancer Test.

This collaboration aims to educate individuals about genetic risks and encourage proactive cancer screening, emphasizing early detection and prevention strategies.

Myriad Genetics recently launched its FirstGene Multiple Prenatal Screen at ACOG2026 in Washington, engaging healthcare experts on genetic care advancements, according to a previous company announcement. The firm has also scheduled participation in two upcoming healthcare conferences as it expands its industry engagement, details of which remain pending as noted in a recent update. These activities reflect Myriad’s ongoing outreach efforts in genetic testing and education.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.